According to Fortune Business Insights, The global AI-enabled medical devices market size was valued at USD 9.11 billion in 2025. The market is projected to grow from USD 10.78 billion in 2026 to USD 45.87 billion by 2034, exhibiting a CAGR of 19.85% during the forecast period. North America dominated the AI enabled medical devices market with a market share of 41.6% in 2025.
The report offers an in-depth analysis of the competitive landscape, market segmentation, and regional presence within the AI enabled Medical Devices Market. It provides valuable insights into market size, growth trajectories, production and consumption trends, and overall revenue performance. The study further identifies the key drivers influencing industry growth while presenting forecasts for upcoming developments.
Additionally, the report highlights new product launches, strategic alliances, joint ventures, marketing initiatives, and recent mergers and acquisitions. It emphasizes promotional strategies and showcases notable industry advancements. The analysis also covers revenue patterns, import–export dynamics, and projected CAGR, while addressing the current challenges and competitive pressures shaping the market landscape.
Get a Free Sample of this Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/ai-enabled-medical-devices-market-115850
Top Companies Covered In AI enabled Medical Devices Market Report:
Medtronic (U.S.)Siemens Healthineers AG (Germany)Koninklijke Philips N.V. (Netherlands)ai, Inc. (U.S.)Intuitive Surgical Operations, Inc. (U.S.)General Electric Company (U.S.)Aidoc (Israel)Digital Diagnostics Inc. (U.S.)TEMPUS (U.S.)iRhythm Technologies, Inc. (U.S.)
Market Overview
The global AI enabled Medical Devices Market is witnessing robust growth, fueled by shifting consumer preferences, rapid technological advancements, and expanding applications across multiple industries. Rising demand, coupled with ongoing innovation and product development, is reshaping the competitive landscape and unlocking new business opportunities. To strengthen their market presence, leading players are increasingly pursuing strategic collaborations, mergers, and acquisitions, while also enhancing their product portfolios. Furthermore, regional expansions, regulatory changes, and broader economic conditions are playing a pivotal role in influencing market dynamics. In this evolving environment, continuous investment in research and development is essential for sustaining long-term growth and securing a competitive edge.
Segmentation:
By Component (Software, Hardware & Devices, and Services), By Technology (Machine Learning & Deep Learning, Natural Language Processing, Computer Vision, and Others), By Specialty (Radiology, Cardiology, Ophthalmology, Neurology, Orthopaedics, Gastroenterology, Pathology, and Others) By Application (Screening and Early Detection, Diagnosis and Interpretation, Monitoring and Alerting, Therapy Planning/Treatment Support, & Others), By End User (Hospitals & ASCs, Specialty Clinics, & Others), and Regional Forecast
Scope of the Report
The comprehensive research report on the AI enabled Medical Devices Market delves into an in-depth analysis of the industry, covering essential aspects such as industry size, market share, prominent players, as well as segments and sub-segments. This document serves as an indispensable resource for gaining profound insights into the current market landscape and its potential growth trajectory until the forecast year.
Market research holds immense significance in deciphering the intricacies of the market dynamics. It enables businesses and marketers to pinpoint key demographics and market segments likely to engage with a particular product or service. Armed with this understanding of consumer preferences and behaviors, key companies can refine their advertising strategies and optimize their approaches effectively.
Trends & Opportunities:
The AI enabled Medical Devices Market is witnessing evolving trends driven by changing consumer preferences, technological advancements, and sustainability initiatives. Companies are increasingly focusing on innovation, product differentiation, and digital transformation to enhance customer engagement and market reach. The growing demand for eco-friendly and premium products also presents significant opportunities for market players. Additionally, expanding e-commerce channels, strategic partnerships, and emerging markets offer avenues for growth and diversification. These trends are expected to shape the industry's trajectory and open up new opportunities for investment and development.
Get a Full Report: https://www.fortunebusinessinsights.com/ai-enabled-medical-devices-market-115850
Regional Analysis:
The global AI enabled Medical Devices Market report focuses on six key regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. It provides detailed insights into new product launches, technological advancements, innovative services, and ongoing R&D efforts. The report includes both qualitative and quantitative market assessments, incorporating PEST analysis, SWOT analysis, and Porter’s Five Forces analysis. It also addresses essential factors such as raw material sources, distribution networks, methodologies, production capacities, industry supply chains, and product specifications.
Our comprehensive research methodology involves data triangulation through both bottom-up and top-down approaches. Primary research was used to validate market estimates, while secondary research gathered detailed information on mergers and acquisitions, collaborations, joint ventures, and agreements. Moreover, we derived key insights into market dynamics, focusing on growth drivers, trends, and challenges.
Recent Developments:
February 2026: GE HealthCare announced a collaboration with Diagnoly to advance AI-enabled fetal ultrasound offerings. This is relevant as it expands AI use in obstetric imaging and supports device-linked ultrasound workflow enhancement.
November 2025: Siemens Healthineers introduced Optiq AI for its latest interventional systems portfolio. The company said the AI-powered imaging chain is designed to deliver higher-quality low-dose images for image-guided procedures across interventional radiology, cardiology, and minimally invasive surgery.